drugset / Trial / NCT03825523

Immediate ART in Subjects With Opportunistic Diseases

NCT03825523

Completed 114 enrolled Gustavo Reyes-Teran
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to compare the clinical response and mortality rate due to opportunistic disease in HIV-infected individuals who start immediate versus conventional antiretroviral therapy (ART). Immediate ART (iART) is defined as starting antiretroviral therapy within the first 48 hours after hospitalization. Conventional ART (cART) is defined as starting antiretroviral therapy once the opportunistic infection is under control at the discretion of the infectious disease specialist.

Timeline

Start
2018-01-29
Primary completion
2025-08-05
Completion
2025-08-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background bictegravir Small molecule
Background emtricitabine Other / unclassified
Background tenofovir alafenamide Small molecule